2014 - The Walter E. Stamm Mentor Award, Infectious Diseases Society of America
His primary areas of investigation include Surgery, Internal medicine, Bacteremia, Staphylococcus aureus and Endocarditis. His work in Surgery addresses issues such as Vancomycin, which are connected to fields such as Antibacterial agent, Methicillin-resistant Staphylococcus aureus and Gentamicin. In his work, Embolism and Chemotherapy is strongly intertwined with Staphylococcal infections, which is a subfield of Internal medicine.
His biological study spans a wide range of topics, including Complication and Hemodialysis. His Staphylococcus aureus research is multidisciplinary, relying on both Blood culture, Incidence and Intensive care medicine. His work deals with themes such as Penicillin and Infective endocarditis, which intersect with Endocarditis.
His primary scientific interests are in Internal medicine, Surgery, Staphylococcus aureus, Endocarditis and Vancomycin. His research in Internal medicine intersects with topics in Antibiotics and Cardiology. His Surgery study combines topics in areas such as Cohort study and Cohort.
His studies deal with areas such as Bacteremia, Microbiology and Intensive care medicine as well as Staphylococcus aureus. His Endocarditis research is multidisciplinary, incorporating elements of Heart valve, Infective endocarditis, Heart disease and Gentamicin. His study explores the link between Vancomycin and topics such as Clinical trial that cross with problems in Randomized controlled trial.
G. Ralph Corey spends much of his time researching Internal medicine, Vancomycin, Iclaprim, Adverse effect and Clinical trial. His study looks at the intersection of Internal medicine and topics like Antibiotics with Staphylococcus aureus and Surrogate endpoint. The various areas that G. Ralph Corey examines in his Vancomycin study include Clinical endpoint, Tolerability and Surgery.
The Clinical trial study combines topics in areas such as Sepsis, Disease, Ceftaroline fosamil and Intensive care medicine. G. Ralph Corey is studying Native Valve Endocarditis, which is a component of Infective endocarditis. His study looks at the relationship between Bloodstream infection and fields such as Mortality rate, as well as how they intersect with chemical problems.
His main research concerns Vancomycin, Internal medicine, Adverse effect, Iclaprim and Clinical trial. G. Ralph Corey has researched Vancomycin in several fields, including Antibiotics, Microbiology and Methicillin-resistant Staphylococcus aureus. He has included themes like Vegetation and Cardiology in his Internal medicine study.
In his study, Surrogate endpoint, Treatment options and Virology is strongly linked to Intensive care medicine, which falls under the umbrella field of Clinical trial. Clinical endpoint is a subfield of Surgery that G. Ralph Corey studies. His work investigates the relationship between Intention-to-treat analysis and topics such as Bacteremia that intersect with problems in Staphylococcus aureus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Jennifer S. Li;Daniel J. Sexton;Nathan Mick;Richard Nettles.
Clinical Infectious Diseases (2000)
Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study
David R. Murdoch;G. Ralph Corey;Bruno Hoen;José M. Miró.
JAMA Internal Medicine (2009)
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Vance G. Fowler;Helen W. Boucher;G. Ralph Corey;Elias Abrutyn.
The New England Journal of Medicine (2006)
Staphylococcus aureus Endocarditis A Consequence of Medical Progress
Vance G. Fowler;Jose M. Miro;Bruno Hoen;Christopher H. Cabell.
Epidemiology of Methicillin-Resistant Staphylococcus aureus
Helen W. Boucher;G. Ralph Corey.
Clinical Infectious Diseases (2008)
Clinical identifiers of complicated Staphylococcus aureus bacteremia.
Vance G. Fowler;Maren K. Olsen;G. Ralph Corey;Christopher W. Woods.
JAMA Internal Medicine (2003)
Catheter-Related Bacteremia and Outcome of Attempted Catheter Salvage in Patients Undergoing Hemodialysis
Kieren A. Marr;Kieren A. Marr;Daniel J. Sexton;Peter J. Conlon;G. Ralph Corey.
Annals of Internal Medicine (1997)
Changing patient characteristics and the effect on mortality in endocarditis.
Christopher H. Cabell;James G. Jollis;Gail E. Peterson;Gail E. Peterson;G. Ralph Corey.
JAMA Internal Medicine (2002)
Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis
Andrew Wang;Eugene Athan;Paul A. Pappas;Vance G. Fowler.
Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients.
Vance G. Fowler;Linda L. Sanders;Daniel J. Sexton;Likuo Kong.
Clinical Infectious Diseases (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: